GlassScriptPhysician profile
Vineet Tyagi
NPI 1992183008
$53,517.67
in general payments reported to CMS, 2019-2025
14 companies · $760 in 2025
The $760 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $5,092 · 2021: $6,529 · 2022: $6,519 · 2023: $29K · 2024: $5,435 · 2025: $760.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $17K · Travel and Lodging: $16K · Food and Beverage: $2,007 · Honoraria: $260.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $17,400.00 |
| Travel and Lodging | $15,710.84 |
| Food and Beverage | $2,006.79 |
| Honoraria | $260.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Think Surgical, INC. | $36,042.54 | 2022-2024 | |
| Smith+Nephew, INC. | $10,000.00 | 2020-2021 | |
| Stryker Corporation | $6,769.80 | 2020-2025 | Mako, Insignia, Motionsense Digital Goniometer |
| Pacira Pharmaceuticals Incorporated | $299.59 | 2022-2023 | Exparel |
| Depuy Synthes Sales INC. | $102.08 | 2022-2025 | Orthovisc, Monovisc |
| Bioventus LLC | $80.12 | 2022-2024 | Durolane, L360 Thigh System |
| Medtronic, INC. | $59.00 | 2022 | |
| Davol INC. | $50.58 | 2025 | Channel Drain |
| Molnlycke Health Care US, LLC | $30.64 | 2025 | Avance, Mepilex Border Post-Op Ag |
| Ferring Pharmaceuticals INC. | $21.83 | 2025 | Euflexxa |
| Pfizer INC. | $16.10 | 2024 | |
| Merz Pharmaceuticals, LLC | $15.88 | 2024 | Xeomin |
| Glaxosmithkline, LLC. | $14.94 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $14.57 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vineet Tyagi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.